Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Fudan University Shanghai Cancer Center

Fudan University Shanghai Cancer Center in Shanghai, Shanghai Municipality, China is listed as a site for 808 registered clinical trials, 447 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 808
Ongoing 447

This page covers the site record Fudan University Shanghai Cancer Center in Shanghai, Shanghai Municipality, China: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Fudan University Shanghai Cancer Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 808 trials counted.

  • Phase 1 105 trials
  • Phase 1/2 85 trials
  • Phase 2 274 trials
  • Phase 2/3 13 trials
  • Phase 3 172 trials
  • Phase 4 6 trials
  • Not applicable 64 trials
  • Observational 89 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 447 trials
  • Completed 139 trials
  • Terminated 27 trials
  • Other 195 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 133

2000: 1 trials (Phase 2 1) 2009: 1 trials (Phase 1/2 1) 2010: 8 trials (Phase 3 1, Phase 2/3 1, Phase 2 5, Phase 1 1) 2011: 4 trials (Phase 2 4) 2012: 11 trials (Observational 1, Phase 3 4, Phase 2 5, Phase 1 1) 2013: 7 trials (Phase 3 1, Phase 2 5, Phase 1 1) 2014: 7 trials (Phase 3 5, Phase 2 1, Phase 1 1) 2015: 16 trials (Observational 1, Not applicable 3, Phase 3 5, Phase 2/3 1, Phase 2 5, Phase 1 1) 2016: 20 trials (Observational 1, Not applicable 3, Phase 3 5, Phase 2/3 1, Phase 2 3, Phase 1/2 4, Phase 1 3) 2017: 32 trials (Observational 7, Not applicable 3, Phase 3 5, Phase 2/3 1, Phase 2 10, Phase 1/2 2, Phase 1 4) 2018: 38 trials (Observational 8, Not applicable 6, Phase 4 1, Phase 3 11, Phase 2/3 2, Phase 2 6, Phase 1/2 2, Phase 1 2) 2019: 24 trials (Observational 3, Not applicable 2, Phase 3 8, Phase 2 4, Phase 1/2 4, Phase 1 3) 2020: 61 trials (Observational 5, Not applicable 7, Phase 4 1, Phase 3 9, Phase 2 21, Phase 1/2 9, Phase 1 9) 2021: 82 trials (Observational 12, Not applicable 4, Phase 3 14, Phase 2/3 1, Phase 2 32, Phase 1/2 5, Phase 1 14) 2022: 76 trials (Observational 8, Not applicable 6, Phase 3 13, Phase 2 22, Phase 1/2 13, Phase 1 14) 2023: 100 trials (Observational 10, Not applicable 8, Phase 4 1, Phase 3 21, Phase 2 37, Phase 1/2 10, Phase 1 13) 2024: 101 trials (Observational 13, Not applicable 6, Phase 3 16, Phase 2/3 1, Phase 2 44, Phase 1/2 7, Phase 1 14) 2025: 133 trials (Observational 12, Not applicable 9, Phase 4 2, Phase 3 31, Phase 2/3 4, Phase 2 42, Phase 1/2 18, Phase 1 15)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 84
2025 133
2024 101
2023 100
2022 76
2021 82
2020 61
2019 24
2018 38
2017 32

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.